A detailed history of Bruce G. Allen Investments, LLC transactions in Incyte Corp stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 128 shares of INCY stock, worth $10,361. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128
Previous 128 -0.0%
Holding current value
$10,361
Previous $7.76 Million 9.05%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$51.18 - $63.75 $5,169 - $6,438
101 Added 374.07%
128 $7.76 Million
Q1 2024

Apr 10, 2024

BUY
$56.55 - $66.59 $282 - $332
5 Added 22.73%
27 $1.54 Million
Q4 2023

Jan 10, 2024

BUY
$52.16 - $64.19 $1,147 - $1,412
22 New
22 $1.38 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.